Format

Send to

Choose Destination
  • Filters activated: Field: Title Word. Clear all
Nanotechnol Sci Appl. 2015 Nov 19;8:55-66. doi: 10.2147/NSA.S49052. eCollection 2015.

Nanotechnology-based inhalation treatments for lung cancer: state of the art.

Author information

1
Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard, New Delhi, India.
2
Nanomedicine Research Lab, Faculty of Pharmacy, Jamia Hamdard, New Delhi, India ; Centre de Biophysique Moléculaire(CBM)-CNRS UPR4301, University of Orléans, Orléans Cedex 2, France.
3
Department of Pharmaceutics, Abhilashi College of Pharmacy, Mandi, HP, India.
4
Department of Pharmaceutics, College of Pharmacy, Najran University, Saudi Arabia.
5
Department of Biosciences, Jamia Millia Islamia, New Delhi, India.
6
Metabolomics and Enzymology Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
7
Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard, New Delhi, India ; Nanomedicine Research Lab, Faculty of Pharmacy, Jamia Hamdard, New Delhi, India.

Abstract

Considering the challenges associated with conventional chemotherapy, targeted and local delivery of chemotherapeutics via nanoparticle (NP) carriers to the lungs is an emerging area of interest. Recent studies and growing clinical application in cancer nanotechnology showed the huge potential of NPs as drug carriers in cancer therapy, including in lung carcinoma for diagnosis, imaging, and theranostics. Researchers have confirmed that nanotechnology-based inhalation chemotherapy is viable and more effective than conventional chemotherapy, with lesser side effects. Recently, many nanocarriers have been investigated, including liposomes, polymeric micelles, polymeric NPs, solid lipid NPs, and inorganic NPs for inhalation treatments of lung cancer. Yet, the toxicity of such nanomaterials to the lungs tissues and further distribution to other organs due to systemic absorption on inhalation delivery is a debatable concern. Here, prospect of NPs-based local lung cancer targeting through inhalation route as well as its associated challenges are discussed.

KEYWORDS:

drug targeting; inhalational chemotherapy; lung cancer; nanoparticles; nanotoxicity

Supplemental Content

Full text links

Icon for Dove Medical Press Icon for PubMed Central
Loading ...
Support Center